Notably, Opal multiplex immunofluorescence staining demonstrated that some p‐TFCP2L1‐positive cells in bladder tumors highly expressed bladder cancer SC (CSC) markers including SALL4 and CD44 (Figs 4C and EV4B). This evidence concerns the gene TFCP2L1 and urinary bladder cancer.